• Info
  • Insider Ownership

Insider Trading & Ownership of Mark Chin

Location
London, United Kingdom
Summary
The estimated net worth of Mark Chin is at least $35,503,158 dollars as of 13 Jun 2025. Mark Chin is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $35.48M. Mark Chin is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $25.6K.
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Mark Chin and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Mark Chin has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $35,503,158.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: IMARA Inc. ($35,477,530).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Mark Chin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN IMARA Inc. Director $35,477,530 02 Jun 2022
ITRM Iterum Therapeutics plc Director $25,628 15 Jun 2023
HARP Harpoon Therapeutics, Inc. Director $0 08 Mar 2024
IRON Disc Medicine, Inc. Director 11 Jun 2025
PYXS Pyxis Oncology, Inc. Former Director 21 Apr 2022

Insider Transactions Reported by Mark Chin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored